-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Abeona Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2010 to 2023.
- Abeona Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $145K, a 30.6% increase year-over-year.
- Abeona Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $745K.
- Abeona Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $2.94M, a 1987% increase from 2022.
- Abeona Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $141K.
- Abeona Therapeutics Inc. annual Nonoperating Income (Expense) for 2017 was $517K, a 74.3% decline from 2016.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)